Latest Breaking News On - Nick bastin - Page 4 : comparemela.com

Sequana Medical NV: Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2 0 for treatment of congestive heart failure

Sequana Medical NV: Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2 0 for treatment of congestive heart failure
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesCian crosbieJonathan edwardsNick bastinStrategic communicationsYork heart associationCompany or sequanamedicalEuronext brusselsSafety monitoring boardChief medical officerSequana medicalChief executive officerNew york heart associationSeattle heart failureNorth americanPre market approval

Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2 0 for treatment of congestive heart failure

PRESS RELEASE Ghent, Belgium – 10 July 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of…

United statesCian crosbieJonathan edwardsNick bastinYork heart associationStrategic communicationsCompany or sequanamedicalSequana medicalEuronext brusselsSafety monitoring boardChief medical officerChief executive officerNew york heart associationSeattle heart failureNorth americanPre market approval

Biocytogen Pharmaceuticals (Beijing) Co , Ltd : Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics

Biocytogen Pharmaceuticals (Beijing) Co , Ltd : Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergSan franciscoUnited statesYuelei shenHana malikHelena batesHaimen jiangsuBertrand damourIntegrum renmiceNick bastinAtlas venturePheon optimum strategic communicationsResearch corporation technologiesBiocytogen pharmaceuticals beijing co ltdExclusive license agreementOncological target antibody

Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics

Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoHaimen jiangsuIntegrum renmiceYuelei shenHana malikHelena batesBertrand damourNick bastinPheon optimum strategic communicationsAtlas ventureResearch corporation technologiesBiocytogen pharmaceuticals beijing co ltdExclusive license agreementOncological target antibodyDevelop best in class

1,000th alfapump® implant completed

1,000th alfapump® implant completed
kentuckytoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kentuckytoday.com Daily Mail and Mail on Sunday newspapers.

United statesNick bastinJonathan edwardsCian crosbieLiver internationalCompany or sequanaStrategic communicationsNorth americanSequana medicalEuronext brusselsChief executive officerPre market approvalNorth americathroughMajor adverse events